Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and "booster" dose

Haematologica. 2022 May 1;107(5):1218. doi: 10.3324/haematol.2022.280619.

Authors

Immacolata Attolico¹, Francesco Tarantini², Paola Carluccio¹, Pellegrino Musto³

Affiliations

¹ Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari Italy.
² Department of Emergency and Organ Transplantation, "Aldo Moro"University School of Medicine, Bari, Italy.
³ Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari Italy; Department of Emergency and Organ Transplantation, "Aldo Moro"University School of Medicine, Bari, Italy.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19* / prevention & control
Hematopoietic Stem Cell Transplantation*
Humans
SARS-CoV-2
Vaccination

Substances

Antibodies, Viral